Andreas Behren

Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?

Oliver Klein, Damien Kee, Adnan Nagrial, Ben Markman, Craig Underhill, Michael Michael, Andreas Behren, Jodie Palmer, Niall C Tebbutt, Matteo S Carlino, Jonathan Cebon

Journal article  |  2023  |  Cancer

Author Correction: Pan-cancer analysis of whole genomes.

undefined ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium

Journal article  |  2023  |  Nature

In the published version of this paper, the list of members of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium and the..

Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry.

Luke T Quigley, Lokman Pang, Elnaz Tavancheh, Matthias Ernst, Andreas Behren, Jennifer Huynh, Jessica Da Gama Duarte

Journal article  |  2023  |  STAR Protoc

Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates that can develop within or adjacent to tumors, but protocols t..

Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours.

Vinayak Bhandari, Constance H Li, Robert G Bristow, Paul C Boutros, undefined PCAWG Consortium

Journal article  |  2022  |  Nat Commun

In the published version of this paper, the members of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortiumwere listed in t..

192 Characterization of antibodies against BTN2A1 for Vδ2 γδ T cell-based tumor immunotherapy

Kok Fei Chan, Simone Ostrouska, Ranjeeta Prasad, Daria Kurtov, Andrew Hammet, Marc Rigau, Adam Uldrich, Andreas Behren

Conference Proceedings  |  2022  |  Regular and Young Investigator Award Abstracts

SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy.

Junrong Li, Alain Wuethrich, Zhen Zhang, Jing Wang, Lynlee L Lin, Andreas Behren, Yuling Wang, Matt Trau

Journal article  |  2022  |  Anal Chem

Immune checkpoint blockade (ICB) therapy has achieved remarkable success in many cancers including melanoma. However, ICB therapy ..

Spliced HLA peptides, a novel source for melanoma immunotherapy

Pouya Faridi, Katherine Woods, Julian Viviane, Jamie Rossjohn, Ralf Schittenhelm, Andreas Behren, Nathan Croft, Anthony Purcell

Journal article  |  2022  |  Molecular Immunology

Abstract 1373: PeptidePCR: Direct identification of cancer vaccine targets from scant clinical samples

Sri H Ramarathinam, Pouya Faridi, Angela Peng, Pacman Szeto, Nicholas C Wong, Andreas Behren, Mark Shackleton, Anthony W Purcell

Journal article  |  2022  |  Cancer Research

Abstract Background: Peptides presented by Human Leukocyte antigen (HLA) class I and II molecules form an important..

'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors

Ashray Gunjur, Andrea J Manrique-Rincon, Oliver Klein, Andreas Behren, Trevor D Lawley, Sarah J Welsh, David J Adams

Journal article  |  2022  |  JOURNAL OF PATHOLOGY

Immune checkpoint inhibitors (ICIs) have revolutionised oncology and are now standard-of-care for the treatment of a wide variety ..

γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.

Kok Fei Chan, Jessica Da Gama Duarte, Simone Ostrouska, Andreas Behren

Journal article  |  2022  |  Front Immunol

A growing number of studies have shown that γδ T cells play a pivotal role in mediating the clearance of tumors and pathogen-infec..